Personalized Treatment: Integrating Data for Del(17p) Patient Care
Clinicians integrate SEQUOIA trial results, BTK inhibitor studies, and real-world data to personalize treatment for del(17p) patients, considering tolerability, comorbidities, and patient goals for optimal care.